4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001641172-25-003118
CEO and CFO bought 3,600 shares at $9.10 ($32,760)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2025-04-07 | Purchase | +3,600 | $9.10 | $32,760 | 5,561,602 | D: show line 1 in the form |
| Open-market purchases · 3,600 sh · avg $9.10 · $32,760 | |||||||
Loading xslF345X05/ownership.xml…